JNJ
Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs · BCBA:JNJ
29,600.00 ARS−280.00 −0.94%
Johnson & Johnson Shs Cert Deposito Arg Repr 0.066666666 Shs (BCBA:JNJ) last traded at 29,600.00 ARS, down 0.94% on the day. Over the past year the stock is up 54.17%. Its 52-week range is 18,060.00 to 31,080.00. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open30,060.00
Day range29,500.00 – 30,060.00
52-week range18,060.00 – 31,080.00
Volume5.08 K
Average volume (10 days)18.00 K
Market cap (USD)651.32 B
P/E47.37
EPS (TTM) (USD)0.4093
Dividend yield1.09%
Beta (1 year)−0.1125
Revenue (TTM) (USD)93.79 B
Employees140.80 K
Performance
−0.80%1 week
+5.34%1 month
+9.55%3 months
+33.03%6 months
+35.78%Year to date
+54.17%1 year
Technical reading
Bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- How health care is on the ballot in the midtermsSeeking Alpha · 03 Nov 2026
- Most and least shorted mid- to mega-cap healthcare stocks at the end of OctoberSeeking Alpha · 03 Nov 2026
- Johnson & Johnson reports 94% success rate in trial of coronary artery deviceSeeking Alpha · 01 Nov 2026
- Johnson & Johnson reports lower mortality rates with Impella heart pumpsSeeking Alpha · 01 Nov 2026
- J&J Reports Positive Survival And Outcomes With Impella In HrpciReuters · 01 Nov 2026
- Data Show Positive Survival and Patient Outcomes with Best-Practice Impella Support in HRPCI, in Contrast to CHIP-BCIS3 Study ResultsBusinessWire · 01 Nov 2026
- Ayushman Bharat Digital Mission Can Transform Healthcare Through Data, Says NITI Aayog MemberBusinessworld · 01 Nov 2026
- JNJ's MedTech Segment Disappoints in Q3: Will Growth Rebound in Q4?Zacks · 30 Oct 2026
Market data is delayed as each exchange requires (see data coverage). SuperCharting is charting software and gives no investment advice.